Open access
Aug 2026
Development of therapeutic PD-1 monoclonal antibodies for treatment of canine tumor.
The results suggest that 2H4 has potential for the treatment of tumors, and this antibody will need to undergo canine-specific modification, and dogs with spontaneous cancer will need to be selected to further evaluate its clinical efficacy.
Jinquan He, Xuan Yin, Anqi Xie et al.
· Veterinary Immunology and Im... · 0 citations